[Treatment of Crohn disease with anti-tumor necrosis factor alpha].
Rasmussen
S N
SN
H:S Hvidovre Hospital, gastroenheden, medicinsk sektor.
Petersen
J A
JA
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab
Behandling af morbus Crohn med anti-tumornekrosis-faktor-alpha.